awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q44310507-9427124A-EAF2-4024-A3A8-F066C90D1BEA
Q44310507-9427124A-EAF2-4024-A3A8-F066C90D1BEA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44310507-9427124A-EAF2-4024-A3A8-F066C90D1BEA
A patient-centred approach to treatment with incretin-based agents in patients with type 2 diabetes.
P2860
Q44310507-9427124A-EAF2-4024-A3A8-F066C90D1BEA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44310507-9427124A-EAF2-4024-A3A8-F066C90D1BEA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
96e704144536a92efea9cf62224a09c1ad18a728
P2860
Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment.